FHC Undeland will have access to Datamonitor Healthcare during 2018 to support Your needs by Identify unmet needs Prioritize market opportunities Make informed decisions and much more …….. Please contact… read more →
Early business strategy to optimise a new drug’s product differentiation & chances of market success
by: Sven Undeland, FHC Undeland, and PCG Clinical Services Drug development is a huge investment for small and large pharmaceutical companies, that is both lengthy and risky. Reducing time to market and increasing… read more →
I look forward to participate at Nordic Life Science Days again, please send me your contact details and we can set up a meeting or request a meeting through Partnering… read more →
Please follow link to Evaluate Group and down load PDF report. http://www.evaluategroup.com/public/PressReleases/EPVantage-PD1-PDL1-Combination-Therapies-Revolution.aspx Enjoy the information /Sven
During 2017 FHC Undeland has access to Datamonitor report library covering many disease areas and strategic areas like market access and pricing. Please contact me for more information. //Sven
Recent Comments